Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Pfizer and BioNTech received U.S. FDA approval for their updated COVID-19 vaccine formula, COMIRNATY XFG, targeting the XFG variant for adults 65 and older and high-risk individuals aged 5-64. The vaccine aligns with FDA guidance to better match circulating variants and will begin shipping immediately to ensure rapid seasonal access. Approval is ba…